Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Boehringer Ingelheim4,340 enrolled

Overview

Non-interventional, observational study of physicians' use of Dabigatran etexilate for stroke prevention in patients with atrial fibrillation and mild to moderate renal impairment

Study Type

OBSERVATIONAL

Enrollment

4,340

Conditions

Atrial Fibrillation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * patients with atrial fibrillation foreseen for Pradaxa anticoagulation according to physician's decision for stroke prevention * patients with mild or moderate renal impairment * age \>= 18 years at enrollment Exclusion criteria: \- severe renal impairment (Creatinine Clearance \< 30 ml/min)

Locations (1616)

Outcomes

Primary Outcomes

Creatinine Clearance (Recalculated Using Entries of Age, Gender, Body Weight and Serum Creatinine Made by the Physician)

The creatinine clearance was recalculated with the Cockcroft-Gault formula using age, gender, body weight, and serum creatinine.

Time frame: One single observation time point: at the time of prescription before the first intake of dabigatran etexilate

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Boehringer Ingelheim Investigational Site 626

Aachen, Germany

Boehringer Ingelheim Investigational Site 627

Aachen, Germany

Boehringer Ingelheim Investigational Site 642

Aachen, Germany

Boehringer Ingelheim Investigational Site 643

Aachen, Germany

Boehringer Ingelheim Investigational Site 156

Aalen, Germany

Boehringer Ingelheim Investigational Site 159

Aalen, Germany

Boehringer Ingelheim Investigational Site 472

Aarbergen, Germany

Boehringer Ingelheim Investigational Site 830

Ahaus, Germany

Boehringer Ingelheim Investigational Site 834

Ahaus, Germany

Boehringer Ingelheim Investigational Site 853

Ahaus, Germany

...and 1606 more locations